<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pharmjournal</journal-id><journal-title-group><journal-title xml:lang="ru">Разработка и регистрация лекарственных средств</journal-title><trans-title-group xml:lang="en"><trans-title>Drug development &amp; registration</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2305-2066</issn><issn pub-type="epub">2658-5049</issn><publisher><publisher-name>LLC «CPHA»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33380/2305-2066-2026-15-1-2045</article-id><article-id custom-type="elpub" pub-id-type="custom">pharmjournal-2260</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ДОКЛИНИЧЕСКИЕ И КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PRECLINICAL AND CLINICAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Коррекция нарушений психоневрологического статуса, возникающих на фоне хронического токсического поражения головного мозга, блокаторами GPCR/cAMP- и JAC/STAT-сигнальных путей</article-title><trans-title-group xml:lang="en"><trans-title>Correction of psychoneurological disorders arising against the background of chronic toxic brain damage with inhibitors of GPCR/cAMP and JAC/STAT signaling pathways</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0971-7844</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Полякова</surname><given-names>Т. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Polyakova</surname><given-names>T. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>634028, г. Томск, пр. Ленина, д. 3634050, г. Томск, Московский тракт, д. 2</p></bio><bio xml:lang="en"><p>3, prospekt Lenina, Tomsk, 6340282, Moskovsky trakt, Tomsk, 634050</p></bio><email xlink:type="simple">tasha93@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3684-5510</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мирошниченко</surname><given-names>Л. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Miroshnichenko</surname><given-names>L. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>634028, г. Томск, пр. Ленина, д. 3</p></bio><bio xml:lang="en"><p>3, prospekt Lenina, Tomsk, 634028</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4398-9122</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чайковский</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Chaikovskii</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>634028, г. Томск, пр. Ленина, д. 3</p></bio><bio xml:lang="en"><p>3, prospekt Lenina, Tomsk, 634028</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2153-7945</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Белоусов</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Belousov</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>634050, г. Томск, Московский тракт, д. 2</p></bio><bio xml:lang="en"><p>2, Moskovsky trakt, Tomsk, 634050</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9800-0487</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Агафонов</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Agafonov</surname><given-names>V. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>634028, г. Томск, пр. Ленина, д. 3634050, г. Томск, Московский тракт, д. 2</p></bio><bio xml:lang="en"><p>3, prospekt Lenina, Tomsk, 6340282, Moskovsky trakt, Tomsk, 634050</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0384-333X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зюзьков</surname><given-names>Г. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Zyuz'kov</surname><given-names>G. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>634028, г. Томск, пр. Ленина, д. 3</p></bio><bio xml:lang="en"><p>3, prospekt Lenina, Tomsk, 634028</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научно-исследовательский институт фармакологии и регенеративной медицины имени Е. Д. Гольдберга. Томский национальный исследовательский медицинский центр Российской академии наук; Федеральное государственное бюджетное образовательное учреждение высшего образования «Сибирский государственный медицинский университет» Министерства здравоохранения Российской Федерации (ФГБОУ ВО СибГМУ Минздрава России)</institution></aff><aff xml:lang="en"><institution>Goldberg Research Institute of Pharmacology and Regenerative Medicine (GRIPRM). Tomsk National Research Medical Center of the Russian Academy of Sciences; Siberian State Medical University, SSMU</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Научно-исследовательский институт фармакологии и регенеративной медицины имени Е. Д. Гольдберга. Томский национальный исследовательский медицинский центр Российской академии наук</institution></aff><aff xml:lang="en"><institution>Goldberg Research Institute of Pharmacology and Regenerative Medicine (GRIPRM). Tomsk National Research Medical Center of the Russian Academy of Sciences</institution></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Сибирский государственный медицинский университет» Министерства здравоохранения Российской Федерации (ФГБОУ ВО СибГМУ Минздрава России)</institution></aff><aff xml:lang="en"><institution>Siberian State Medical University, SSMU</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>02</day><month>03</month><year>2026</year></pub-date><volume>15</volume><issue>1</issue><fpage>192</fpage><lpage>201</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Полякова Т.Ю., Мирошниченко Л.А., Чайковский А.В., Белоусов М.В., Агафонов В.И., Зюзьков Г.Н., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Полякова Т.Ю., Мирошниченко Л.А., Чайковский А.В., Белоусов М.В., Агафонов В.И., Зюзьков Г.Н.</copyright-holder><copyright-holder xml:lang="en">Polyakova T.Y., Miroshnichenko L.A., Chaikovskii A.V., Belousov M.V., Agafonov V.I., Zyuz'kov G.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmjournal.ru/jour/article/view/2260">https://www.pharmjournal.ru/jour/article/view/2260</self-uri><abstract><sec><title>Введение</title><p>Введение. Нарушения в функционировании ЦНС, возникающие при хроническом употреблении этанола, часто связаны с угнетением полноценного нейрогенеза. При этом одними из ведущих сигнальных каскадов, задействованных в регуляции пролиферации и дифференцировки нейральных и нейрональных стволовых клеток, считаются GPCR/cAMP-зависимый путь и JAK/STAT-сигналинг. Очевидно, что поиск принципиально новых подходов к терапии этаноловой нейродегенерации, путем воздействия на внутриклеточные сигнальные молекулы, весьма актуален и востребован для практической медицины.</p></sec><sec><title>Цель</title><p>Цель. Целью данного исследования явилось изучение влияния ингибиторов JAC/STAT и GPCR/cAMP на психоневрологический статус мышей, состояние стволовых клеток нервной ткани и секрецию нейротрофинов глией в условиях хронического токсического поражения головного мозга.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Исследования проведены на 90 мышах линии С57BL/6. Алкогольную нейродегенерацию моделировали введением per os 30%-го раствора С2Н5ОН в дозе 3 г/кг/сут в течение 8 недель. Ингибиторы JAC/STAT и GPCR/cAMP вводили подкожно 1 раз в сутки в течение 7 дней в дозе 15 и 10 мкг/кг соответственно. Психофармакологические эффекты блокаторов оценивали в тесте «Открытое поле» и по степени сохранности условного рефлекса пассивного избегания. Культуральными методами изучали содержание нейральных стволовых клеток и коммитированных нейрональных предшественников в субвентрикулярной зоне головного мозга, их пролиферативную активность и интенсивность созревания, исследовали продукцию нейротрофных факторов клетками глии.</p></sec><sec><title>Результаты и обсуждение</title><p>Результаты и обсуждение. Введение ингибиторов JAC/STAT и GPCR/cAMP корригировало функциональные признаки патологии мозга алкогольного генеза (наблюдалась отмена изменений ориентировочно-исследовательского поведения). При этом курсовое применение ингибитора GPCR/cAMP нивелировало, а введение блокатора JAC/STAT усугубляло снижение уровня воспроизведения условного рефлекса пассивного избегания у алкоголизированных мышей. В группах животных, получавших ингибиторы JAC/STAT и GPCR/cAMP, отмечалось возрастание числа нейральных стволовых клеток и коммитированных нейрональных предшественников, сопровождающееся повышением их митотической активности и интенсивности специализации. Введение ингибитора GPCR/cAMP после моделирования этанолиндуцированного поражения головного мозга сопровождалось повышением секреции нейротрофинов астроцитами и микроглией.</p></sec><sec><title>Заключение</title><p>Заключение. Полученные результаты указывают на перспективность разработки нового подхода к терапии хронического алкогольного поражения головного мозга путем таргетного воздействия на отдельные звенья системы внутриклеточной сигнальной трансдукции, в частности применение ингибиторов GPCR/cAMP. </p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Impaired central nervous system function resulting from chronic ethanol consumption is often associated with suppressed neurogenesis. The GPCR/cAMP-dependent pathway and JAK/STAT signaling are considered to be among the key signaling cascades involved in regulating the proliferation and differentiation of neural and neuronal stem cells. Clearly, the search for fundamentally new approaches to treating ethanol-induced neurodegeneration by targeting intracellular signaling molecules is highly relevant and in demand in practical medicine.</p></sec><sec><title>Aim</title><p>Aim. The aim of this study was to investigate the effect of JAC/STAT and GPCR/cAMP inhibitors on the psychoneurological status of mice, the state of neural stem cells, and the secretion of neurotrophins by glia under conditions of chronic toxic brain injury.</p></sec><sec><title>Material and methods</title><p>Material and methods. The studies were conducted on 90 C57BL/6 mice. Alcohol-induced neurodegeneration was modeled by per os administration of 30 % C2H5OH solution at a dose of 3 g/kg/day for 8 weeks. JAC/STAT and GPCR/cAMP inhibitors were administered subcutaneously once a day for 7 days at a dose of 15 and 10 μg/kg, respectively. The psychopharmacological effects of the blockers were assessed in the open field test and by the degree of preservation of the conditioned passive avoidance reflex. The content of neural stem cells and committed neuronal precursors in the subventricular zone of the brain, their proliferative activity and maturation intensity were studied using cultural methods; the production of neurotrophic factors by glial cells was investigated.</p></sec><sec><title>Results and discussion</title><p>Results and discussion. The introduction of JAC/STAT and GPCR/cAMP inhibitors corrected the functional signs of alcoholic brain pathology (changes in exploratory behavior were abolished). At the same time, the course use of a GPCR/cAMP inhibitor leveled out, and the introduction of a JAC/STAT blocker aggravated the decrease in the level of reproduction of the conditioned passive avoidance reflex in alcoholized mice. In the groups of animals receiving JAC/STAT and GPCR/cAMP inhibitors, an increase in the number of neural stem cells and committed neuronal precursors was observed, accompanied by an increase in their mitotic activity and intensity of specialization. The introduction of a GPCR/cAMP inhibitor after modeling ethanol-induced brain damage was accompanied by an increase in the secretion of neurotrophins by astrocytes and microglia.</p></sec><sec><title>Conclusion</title><p>Conclusion. The obtained results indicate the prospects of developing a new approach to the treatment of chronic alcohol-induced brain damage by targeting individual links in the intracellular signal transduction system, in particular, the use of GPCR/cAMP inhibitors.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>токсическое поражение головного мозга</kwd><kwd>этанол</kwd><kwd>ингибитор JAC/STAT</kwd><kwd>ингибитор GPCR/cAMP</kwd><kwd>нейротрофины</kwd><kwd>нейральные стволовые клетки</kwd><kwd>церебропротекторные средства</kwd></kwd-group><kwd-group xml:lang="en"><kwd>toxic brain damage</kwd><kwd>ethanol</kwd><kwd>JAC/STAT inhibitor</kwd><kwd>GPCR/cAMP inhibitor</kwd><kwd>neurotrophins</kwd><kwd>neural stem cells</kwd><kwd>cerebroprotective agents</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена в рамках государственного задания Министерства науки и высшего образования Российской Федерации по теме FGWM-2022-0018.</funding-statement><funding-statement xml:lang="en">This work was supported by the Russian Ministry of Science and Higher Education's state assignment, Project FGWM-2022-0018.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Livingston G., Huntley J., Sommerlad A., Ames D., Ballard C., Banerjee S., Brayne C., Burns A., Cohen-Mansfield J., Cooper C., Costafreda S. G., Dias A., Fox N., Gitlin L. N., Howard R., Kales H. C., Kivimäki M., Larson E. B., Ogunniyi A., Orgeta V., Ritchie K., Rockwood K., Sampson E. L., Samus Q., Schneider L. S., Selbæk G., Teri L., Mukadam N. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet. 2020;396(10248):413–446. DOI: 10.1016/S0140-6736(20)30367-6.</mixed-citation><mixed-citation xml:lang="en">Livingston G., Huntley J., Sommerlad A., Ames D., Ballard C., Banerjee S., Brayne C., Burns A., Cohen-Mansfield J., Cooper C., Costafreda S. G., Dias A., Fox N., Gitlin L. N., Howard R., Kales H. C., Kivimäki M., Larson E. B., Ogunniyi A., Orgeta V., Ritchie K., Rockwood K., Sampson E. L., Samus Q., Schneider L. S., Selbæk G., Teri L., Mukadam N. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet. 2020;396(10248):413–446. DOI: 10.1016/S0140-6736(20)30367-6.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Lees B., Meredith L. R., Kirkland A. E., Bryant B. E., Squeglia L. M. Effect of alcohol use on the adolescent brain and behavior. Pharmacology, biochemistry, and behavior. 2020;192:172906. DOI: 10.1016/j.pbb.2020.172906.</mixed-citation><mixed-citation xml:lang="en">Lees B., Meredith L. R., Kirkland A. E., Bryant B. E., Squeglia L. M. Effect of alcohol use on the adolescent brain and behavior. Pharmacology, biochemistry, and behavior. 2020;192:172906. DOI: 10.1016/j.pbb.2020.172906.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Mudyanselage A. W., Wijamunige B. C., Kocon A., Turner R., McLean D., Morentin B., Callado L. F., Carter W. G. Alcohol Triggers the Accumulation of Oxidatively Damaged Proteins in Neuronal Cells and Tissues. Antioxidants. 2024;13(5):580. DOI: 10.3390/antiox13050580.</mixed-citation><mixed-citation xml:lang="en">Mudyanselage A. W., Wijamunige B. C., Kocon A., Turner R., McLean D., Morentin B., Callado L. F., Carter W. G. Alcohol Triggers the Accumulation of Oxidatively Damaged Proteins in Neuronal Cells and Tissues. Antioxidants. 2024;13(5):580. DOI: 10.3390/antiox13050580.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Gupta A., Khan H., Kaur A., Singh T. G. Novel Targets Explored in the Treatment of Alcohol Withdrawal Syndrome. CNS &amp; Neurological Disorders – Drug Targets. 2021;20(2):158–173. DOI: 10.2174/1871527319999201118155721.</mixed-citation><mixed-citation xml:lang="en">Gupta A., Khan H., Kaur A., Singh T. G. Novel Targets Explored in the Treatment of Alcohol Withdrawal Syndrome. CNS &amp; Neurological Disorders – Drug Targets. 2021;20(2):158–173. DOI: 10.2174/1871527319999201118155721.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Crews F. T., Macht V., Vetreno R. P. Epigenetic regulation of microglia and neurons by proinflammatory signaling following adolescent intermittent ethanol (AIE) exposure and in human AUD. Advances in Drug and Alcohol Research. 2024;4:12094. DOI: 10.3389/adar.2024.12094.</mixed-citation><mixed-citation xml:lang="en">Crews F. T., Macht V., Vetreno R. P. Epigenetic regulation of microglia and neurons by proinflammatory signaling following adolescent intermittent ethanol (AIE) exposure and in human AUD. Advances in Drug and Alcohol Research. 2024;4:12094. DOI: 10.3389/adar.2024.12094.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Chang H.-M., Wu H.-C., Sun Z.-G., Lian F., Leung P. C. K. Neurotrophins and glial cell line-derived neurotrophic factor in the ovary: physiological and pathophysiological implications. Human Reproduction Update. 2019;25(2):224–242. DOI: 10.1093/humupd/dmy047.</mixed-citation><mixed-citation xml:lang="en">Chang H.-M., Wu H.-C., Sun Z.-G., Lian F., Leung P. C. K. Neurotrophins and glial cell line-derived neurotrophic factor in the ovary: physiological and pathophysiological implications. Human Reproduction Update. 2019;25(2):224–242. DOI: 10.1093/humupd/dmy047.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Amidfar M., de Oliveira J., Kucharska E., Budni J., Kim Y.-K. The role of CREB and BDNF in neurobiology and treatment of Alzheimer’s disease. Life Sciences. 2020;257:118020. DOI: 10.1016/j.lfs.2020.118020.</mixed-citation><mixed-citation xml:lang="en">Amidfar M., de Oliveira J., Kucharska E., Budni J., Kim Y.-K. The role of CREB and BDNF in neurobiology and treatment of Alzheimer’s disease. Life Sciences. 2020;257:118020. DOI: 10.1016/j.lfs.2020.118020.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Yang С.-H., Di Antonio А., Kirschen G. W., Varma P., Hsieh J., Ge S. Circuit Integration Initiation of New Hippocampal Neurons in the Adult Brain. Cell Reports. 2020;30(4):959–968. DOI: 10.1016/j.celrep.2019.12.084.</mixed-citation><mixed-citation xml:lang="en">Yang С.-H., Di Antonio А., Kirschen G. W., Varma P., Hsieh J., Ge S. Circuit Integration Initiation of New Hippocampal Neurons in the Adult Brain. Cell Reports. 2020;30(4):959–968. DOI: 10.1016/j.celrep.2019.12.084.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Poser S. W., Chenoweth J. G., Colantuoni С., Masjkur J., Chrousos G., Bornstein S. R., McKay R. D., Androutsellis-Theotokis A. Concise Review: Reprogramming, Behind the Scenes: Noncanonical Neural Stem Cell Signaling Pathways Reveal New, Unseen Regulators of Tissue Plasticity With Therapeutic Implications. Stem Cells Translational Medicine. 2015;4(11):1251–1257. DOI: 10.5966/sctm.2015-0105.</mixed-citation><mixed-citation xml:lang="en">Poser S. W., Chenoweth J. G., Colantuoni С., Masjkur J., Chrousos G., Bornstein S. R., McKay R. D., Androutsellis-Theotokis A. Concise Review: Reprogramming, Behind the Scenes: Noncanonical Neural Stem Cell Signaling Pathways Reveal New, Unseen Regulators of Tissue Plasticity With Therapeutic Implications. Stem Cells Translational Medicine. 2015;4(11):1251–1257. DOI: 10.5966/sctm.2015-0105.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Zyuz’kov G. N., Miroshnichenko L. A., Polyakova T. Yu., Zhdanov V. V., Simanina E. V., Stavrova L. A., Danilets M. G. Specific Features of Intracellular Signal Transduction in the Regulation of Functions of Neural Stem Cells and Committed Neuronal Progenitors. Bulletin of Experimental Biology and Medicine. 2021;170(4):522–527. DOI: 10.1007/s10517-021-05100-y.</mixed-citation><mixed-citation xml:lang="en">Zyuz’kov G. N., Miroshnichenko L. A., Polyakova T. Yu., Zhdanov V. V., Simanina E. V., Stavrova L. A., Danilets M. G. Specific Features of Intracellular Signal Transduction in the Regulation of Functions of Neural Stem Cells and Committed Neuronal Progenitors. Bulletin of Experimental Biology and Medicine. 2021;170(4):522–527. DOI: 10.1007/s10517-021-05100-y.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Bertola A. Mouse Model of Alcoholic Steatohepatitis. Methods in Molecular Biology. 2020;2164:145–157. DOI: 10.1007/978-1-0716-0704-6_15.</mixed-citation><mixed-citation xml:lang="en">Bertola A. Mouse Model of Alcoholic Steatohepatitis. Methods in Molecular Biology. 2020;2164:145–157. DOI: 10.1007/978-1-0716-0704-6_15.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Nesterova Yu. V., Povet’eva T. N., Suslov N. I., Zyuz’kov G. N., Zhdanov V. V., Fedorova Yu. S., Kul’pin P. V., Shaposhnikov K. V. Correction of Cholinergic Abnormalities in Mnestic Processes with Diterpene Alkaloid Songorine. Bulletin of Experimental Biology and Medicine. 2018;165(1):10–13. DOI: 10.1007/s10517-018-4087-9.</mixed-citation><mixed-citation xml:lang="en">Nesterova Yu. V., Povet’eva T. N., Suslov N. I., Zyuz’kov G. N., Zhdanov V. V., Fedorova Yu. S., Kul’pin P. V., Shaposhnikov K. V. Correction of Cholinergic Abnormalities in Mnestic Processes with Diterpene Alkaloid Songorine. Bulletin of Experimental Biology and Medicine. 2018;165(1):10–13. DOI: 10.1007/s10517-018-4087-9.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kumar A., Pareek V., Faiq M. A., Kumar P., Kumari C., Singh H. N., Ghosh S. K. Transcriptomic analysis of the signature of neurogenesis in human hippocampus suggests restricted progenitor cell progression post-childhood. IBRO Reports. 2020;9:224–232. DOI: 10.1016/j.ibror.2020.08.003.</mixed-citation><mixed-citation xml:lang="en">Kumar A., Pareek V., Faiq M. A., Kumar P., Kumari C., Singh H. N., Ghosh S. K. Transcriptomic analysis of the signature of neurogenesis in human hippocampus suggests restricted progenitor cell progression post-childhood. IBRO Reports. 2020;9:224–232. DOI: 10.1016/j.ibror.2020.08.003.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kantzer C. G., Boutin C., Herzig I. D., Wittwer C., Reiß S., Tiveron M. C., Drewes J., Rockel T. D., Ohlig S., Ninkovic J., Cremer H., Pennartz S., Jungblut M., Bosio A. Anti-ACSA-2 defines a novel monoclonal antibody for prospective isolation of living neonatal and adult astrocytes. Glia. 2017;65:990–1004. DOI: 10.1002/glia.23140.</mixed-citation><mixed-citation xml:lang="en">Kantzer C. G., Boutin C., Herzig I. D., Wittwer C., Reiß S., Tiveron M. C., Drewes J., Rockel T. D., Ohlig S., Ninkovic J., Cremer H., Pennartz S., Jungblut M., Bosio A. Anti-ACSA-2 defines a novel monoclonal antibody for prospective isolation of living neonatal and adult astrocytes. Glia. 2017;65:990–1004. DOI: 10.1002/glia.23140.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Visontay R., Rao R. T., Mewton L. Alcohol use and dementia: new research directions. Current Opinion in Psychiatry. 2021;34(2):165–170. DOI: 10.1097/YCO.0000000000000679.</mixed-citation><mixed-citation xml:lang="en">Visontay R., Rao R. T., Mewton L. Alcohol use and dementia: new research directions. Current Opinion in Psychiatry. 2021;34(2):165–170. DOI: 10.1097/YCO.0000000000000679.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Cserép C., Pósfai B., Dénes Á. Shaping Neuronal Fate: Functional Heterogeneity of Direct Microglia-Neuron Interactions. Neuron. 2021;109(2):222–240. DOI: 10.1016/j.neuron.2020.11.007.</mixed-citation><mixed-citation xml:lang="en">Cserép C., Pósfai B., Dénes Á. Shaping Neuronal Fate: Functional Heterogeneity of Direct Microglia-Neuron Interactions. Neuron. 2021;109(2):222–240. DOI: 10.1016/j.neuron.2020.11.007.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Hu Z., Deng N., Liu K., Zhou N., Sun Y., Zeng W. CNTFSTAT3-IL-6 Axis Mediates Neuroinflammatory Cascade across Schwann Cell-Neuron-Microglia. Cell Reports. 2020;31(7):107657. DOI: 10.1016/j.celrep.2020.107657.</mixed-citation><mixed-citation xml:lang="en">Hu Z., Deng N., Liu K., Zhou N., Sun Y., Zeng W. CNTFSTAT3-IL-6 Axis Mediates Neuroinflammatory Cascade across Schwann Cell-Neuron-Microglia. Cell Reports. 2020;31(7):107657. DOI: 10.1016/j.celrep.2020.107657.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Cooper I. A., Beecher K., Chehrehasa F., Belmer A., Bartlett S. E. Tumour Necrosis Factor in Neuroplasticity, Neurogenesis and Alcohol Use Disorder. Brain Plasticity. 2020;6(1):47–66. DOI: 10.3233/BPL-190095.</mixed-citation><mixed-citation xml:lang="en">Cooper I. A., Beecher K., Chehrehasa F., Belmer A., Bartlett S. E. Tumour Necrosis Factor in Neuroplasticity, Neurogenesis and Alcohol Use Disorder. Brain Plasticity. 2020;6(1):47–66. DOI: 10.3233/BPL-190095.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Xin W., Chan J. R. Myelin plasticity: sculpting circuits in learning and memory. Nature Reviews Neuroscience. 2020;21(12):682–694. DOI: 10.1038/s41583-020-00379-8.</mixed-citation><mixed-citation xml:lang="en">Xin W., Chan J. R. Myelin plasticity: sculpting circuits in learning and memory. Nature Reviews Neuroscience. 2020;21(12):682–694. DOI: 10.1038/s41583-020-00379-8.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
